ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
Go back to ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.63 -0.58 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.21 | 52 Week High | $45.58 | |||
| Open | $50.83 | 52 Week Low | $37.82 | |||
| Day High | $50.92 | P/E | N/A | |||
| Day Low | $50.29 | EPS | $0.00 | |||
| Volume | 2,054,547 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.63 -0.58 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.21 | 52 Week High | $45.58 | |||
| Open | $50.83 | 52 Week Low | $37.82 | |||
| Day High | $50.92 | P/E | N/A | |||
| Day Low | $50.29 | EPS | $0.00 | |||
| Volume | 2,054,547 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.98 -0.44 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.42 | 52 Week High | $37.39 | |||
| Open | $30.28 | 52 Week Low | $28.25 | |||
| Day High | $30.32 | P/E | 18.17 | |||
| Day Low | $29.81 | EPS | $1.65 | |||
| Volume | 14,139,236 | |||||



